1. Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer

   • Paola Ulivi
   • Rosella Silvestrini

   Review 01 November 2013 Pages: 439 - 448

2. PEGylated liposomal Gemcitabine: insights into a potential breast cancer therapeutic

   • Anne-Laure Papa
   • Almas Sidiqui
   • Rania Harfouche

   Original Paper 01 October 2013 Pages: 449 - 457

   

3. Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole

   • Akhilesh Rawat
   • Gopisetty Gopal
   • Thangarajan Rajkumar

   Original Paper 27 September 2013 Pages: 459 - 467

   

4. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma

   • Bartosz Pula
   • Mateusz Olbromski
   • Marzena Podhorska-Okolow

   Original Paper 25 September 2013 Pages: 469 - 483

   

5. Increase in ezrin expression from benign to malignant breast tumours

   • Daphne Gschwantler-Kaulich
   • Camilla Natter
   • Christian F. Singer

   Original Paper 16 October 2013 Pages: 485 - 491

   

6. Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway

   • Jeong Su Park
   • Su Yun Choi
   • Young Yang

   Original Paper 10 October 2013 Pages: 493 - 503

   

7. Macrophages as potential targets for zoledronic acid outside the skeleton—evidence from in vitro and in vivo models

   • T. L. Rogers
   • N. Wind
   • I. Holen

   OriginalPaper 01 November 2013 Pages: 505 - 514

   

8. siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells

   • Fatemeh Bagheri
   • Shahrokh Safarian
   • Nader Sheibani

   Original Paper 26 November 2013 Pages: 515 - 526